Physician profile
Jason Bowman
NPI 1396278065
$2,471.34
in general payments reported to CMS, 2019-2025
14 companies · $825 in 2025
The $825 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $331 · 2023: $1,163 · 2024: $153 · 2025: $825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,327 · Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,327.09 |
| Food and Beverage | $813.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,003.12 | 2023 | |
| Stryker Corporation | $694.17 | 2023-2025 | Mako, Inbone |
| Treace Medical Concepts, INC. | $167.96 | 2022-2025 | |
| Averitas Pharma INC. | $114.53 | 2023-2025 | Qutenza |
| Depuy Synthes Sales INC. | $111.13 | 2023-2025 | Na, Tfn-Advance, Motoband |
| Integra Lifesciences Corporation | $109.42 | 2022 | |
| Smith+Nephew, INC. | $80.63 | 2022-2023 | Panta 2 |
| Team 1, LLC | $40.40 | 2025 | |
| Davol INC. | $36.42 | 2025 | Surgiphor |
| Rock Medical Orthopedics, INC. | $30.56 | 2022 | |
| Vericel Corporation | $24.16 | 2024 | Maci |
| Innovation Technologies INC | $23.23 | 2025 | Irrisept |
| Biocomposites INC | $21.40 | 2025 | Stimulan |
| Bioventus LLC | $14.21 | 2024 | Durolane |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Bowman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.